Effective Vortioxetine Dose Varies with Extent of Antidepressant Use Across Countries.

about

Effective Vortioxetine Dose Varies with Extent of Antidepressant Use Across Countries.

Item

http://www.wikidata.org/entity/Q49384717

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Effective Vortioxetine Dose Varies with Extent of Antidepressant Use Across Countries.

@en

Effective Vortioxetine Dose Varies with Extent of Antidepressant Use Across Countries.

@nl

type

Item

label

Effective Vortioxetine Dose Varies with Extent of Antidepressant Use Across Countries.

@en

Effective Vortioxetine Dose Varies with Extent of Antidepressant Use Across Countries.

@nl

prefLabel

Effective Vortioxetine Dose Varies with Extent of Antidepressant Use Across Countries.

@en

Effective Vortioxetine Dose Varies with Extent of Antidepressant Use Across Countries.

@nl

P1476

Effective Vortioxetine Dose Varies with Extent of Antidepressant Use Across Countries.

@en

P2093

Cuneyt Tegin

http://www.w3.org/2001/XMLSchema#string

Gulay Tegin

http://www.w3.org/2001/XMLSchema#string

Rif S El-Mallakh

http://www.w3.org/2001/XMLSchema#string

P2860

Projections of global mortality and burden of disease from 2002 to 2030

A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder

Antidepressant Utilization and Suicide in Europe: An Ecological Multi-National Study

The assessment of anxiety states by rating

A new depression scale designed to be sensitive to change

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

A randomized, double-blind, placebo-controlled study of the efficacy and safety of 2 doses of vortioxetine in adults with major depressive disorder.

Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder.

A randomized, double-blind, placebo-controlled 8-week trial of the efficacy and tolerability of multiple doses of Lu AA21004 in adults with major depressive disorder.

P304

26-39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29382958

http://www.w3.org/2001/XMLSchema#string

P932

5765433

http://www.w3.org/2001/XMLSchema#string